INCbase Update Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder that affects different people in different ways. The symptoms, treatment response, and disease course may vary from person to person, or even in the same person at different stages of the disease. As previously reported in 2017, INCbase is a study that intends to…Read More about INCbase
Research grants are made possible through the benevolence of many sources, including the Helen S. Manheimer Research Fund, contributions from individuals who have been personally touched by GBS, CIDP, or variants, and by several commercial sources. Through the generosity of these contributors, to whom the Foundation is most grateful, we are able continue our Research…Read More about 2020 GBS|CIDP Foundation International Research Grants Announced!
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19Read More about Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19.Read More about Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
As part of the GBS|CIDP Foundation International’s mission to provide education and support research, we offer research grants to qualified applicants.Read More about Now Accepting Applications for 2020 Research Grants